Merdury Biopharmaceutical Corporation (TPEX:6932)

Market Cap	2.60B +13.2%
Revenue (ttm)	n/a
Net Income	-51.62M
EPS	-0.12
Shares Out	427.65M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	258,419
Open	6.02
Previous Close	6.07
Day's Range	5.98 - 6.09
52-Week Range	4.71 - 12.20
Beta	-1.11
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Merdury Biopharmaceutical

Merdury Biopharmaceutical Corporation engages in the development of drugs for unmet needs in Taiwan. The company develops StackDose platform, a drug development technology platform that integrates drug formulation, 3D powder printing, and hardware and software technologies to create drug-specific 3D printing production equipment, which can be used as a foundation for pharmaceutical companies to provide hosted services and in-house product development. It also offers formulation design and 3D pharmaceutical processing services. Merdury Biopharma...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2019
• Employees: 16
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6932

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 30, 2026

Data Sources Report a data error